Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Colonic Neoplasms 14 Colorectal Neoplasms 13 Rectal Neoplasms 11 Prostatic Neoplasms 11 Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Endometrial Neoplasms 8 Uterine Cervical Neoplasms 7 Obesity 7 Motor Activity 7 Lung Neoplasms 7 Overweight 6 Depression 6 Small Cell Lung Carcinoma 5 Ovarian Neoplasms 5 Fatigue 5 Breast Carcinoma In Situ 5 Anxiety Disorders 5 Tobacco Use Disorder 4 Sexuality 4 Sexual Dysfunction, Physiological 4 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Intraductal, Noninfiltrating 4 Urinary Bladder Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Carcinoma, Renal Cell 3 Carcinoma, Ovarian Epithelial 3

Interventions

Megestrol Acetate 9 Exercise 6 Standard of Care 4 Olanzapine 3 Ibuprofen 3 Blood Specimen Collection 3 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Melatonin 2 Infliximab 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 dermcidin 1 clazakizumab 1 bermekimab 1 alkaloid GB18 1 Vitamin D 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cachexia × Counseling × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡